Simon Cozens

First-Time-in-Human Study and Prediction of Early Bactericidal Activity for GSK3036656, a Potent Leucyl-tRNA Synthetase Inhibitor for Tuberculosis Treatment

David M. Tenero, Geo Derimanov, Alex Carlton et al. · Antimicrobial Agents and Chemotherapy · 2019 · 70 citations · Full text

Radical curative efficacy of tafenoquine combination regimens in Plasmodium cynomolgi-infected Rhesus monkeys (Macaca mulatta)

Geoffrey S. Dow, Montip Gettayacamin, Pranee Hansukjariya et al. · Malaria Journal · 2011 · 60 citations · Full text

Pharmacokinetics and absolute bioavailability of mepolizumab following administration at subcutaneous and intramuscular sites

Héctor Ortega, Steve Yancey, Simon Cozens · Clinical Pharmacology in Drug Development · 2013 · 31 citations

GSK962040: a small molecule motilin receptor agonist which increases gastrointestinal motility in conscious dogs

Shawn C. Leming, John Broad, Simon Cozens et al. · Neurogastroenterology & Motility · 2011 · 26 citations